VFEND – Voriconazole uses, dose and side effects

}

50 mg and 200 mg film-coated tablets
voriconazole

What VFEND is and what it is used for

VFEND contains the active substance voriconazole. VFEND is a medicine against fungal infections. It works by killing or stopping the growth of the fungi that cause the infection.

VFEND is used to treat patients (adults and children from 2 years of age) with:

  • invasive aspergillosis (a type of fungal infection caused by Aspergillus sp )
  • candidemia (another type of fungal infection caused by Candida sp ) in non- neutropenic patients (patients without abnormally low white blood cell counts )
  • severe invasive Candida sp . infection when the fungus is resistant to fluconazole (another antifungal medicine)
  • severe fungal infections caused by Scedosporium sp . or Fusarium sp . (two different mushroom species).

VFEND is intended for patients with worsening and potentially life-threatening fungal infections.

Preventive treatment in stem cell transplant patients who are at high risk of developing fungal infection.

This product should only be used under medical supervision.

What you need to know before you use VFEND

Do not use VFEND

  • if you are allergic to voriconazole or any of the other ingredients of this medicine (listed in section 6).

It is very important that you tell your doctor or pharmacist if you are taking or have taken any other medicines, even those without a prescription, or herbal remedies.

The following medicines must not be taken during your treatment with VFEND:

  • terfenadine (used for allergy )
  • astemizole (used for allergy )
  • cisapride (used for stomach upset)
  • pimozide (used to treat mental illness)
  • quinidine (used for irregular heartbeat)
  • ivabradine (used for symptoms of chronic heart failure )
  • rifampicin (used in the treatment of tuberculosis )
  • efavirenz (used in the treatment of HIV ) at a dose of 400 mg or more once daily
  • carbamazepine (used to treat seizures)
  • phenobarbital (used for severe sleep disorders and convulsions)
  • ergot alkaloids (eg, ergotamine , dihydroergotamine; used for migraine )
  • sirolimus (used in transplant patients)
  • ritonavir (used in the treatment of HIV ) at a dose of 400 mg or more twice daily
  • St. John’s wort (natural medicine)
  • naloxegol (used to treat constipation specifically caused by painkillers called opioids (eg morphine, oxycodone, fentanyl , tramadol, codeine ))
  • tolvaptan (used to treat hyponatremia (low levels of sodium in the blood) or to slow the deterioration of kidney function in patients with polycystic kidney disease)
  • lurasidone (used to treat depression)
  • venetoclax (used in the treatment of patients with chronic lymphocytic leukemia – CLL )

Warnings and precautions

Talk to your doctor, pharmacist or nurse before using VFEND if:

  • you have previously had an allergic reaction to other azoles
  • you have or have previously had liver disease. If you have liver disease, your doctor may prescribe a lower dose of VFEND. The doctor must also use blood tests to check your liver function while you are being treated with VFEND
  • you have a known disease of the heart muscle, irregular heartbeats, slow heartbeats or an ECG change called “long QTc syndrome”.

Avoid all sunlight and sun exposure while you are being treated with VFEND. It is important to cover exposed areas of the skin and to use sunscreen with a high sun protection factor (SPF), as the skin can become more sensitive to the sun’s UV rays. These precautions also apply to children.

While you are being treated with VFEND, tell your doctor immediately if you receive

  • sun damage
  • skin rash or blisters
  • bone pain

If you develop the above skin problems, your doctor may refer you to a dermatologist who, after a consultation, may decide that it is important for you to be examined regularly. There is a small risk of developing skin cancer during long-term use with VFEND.

Tell your doctor if you develop signs of ‘adrenal insufficiency’. This means that the adrenal glands do not produce enough of certain steroid hormones such as cortisol , which can lead to symptoms such as chronic or prolonged fatigue, muscle weakness, loss of appetite, weight loss, abdominal pain.

Talk to your doctor if you develop signs of Cushing’s syndrome. This means that the body produces too much of the hormone cortisol , which can lead to symptoms such as weight gain, lumps of fat between the shoulder blades, a round face, darker skin on the stomach, thighs, breasts and arms, thin skin, bruising more easily, high blood sugar, excessive hair growth, excessive sweating.

Your doctor checks liver and kidney function by taking certain blood samples.

Children and young people

VFEND should not be given to children under 2 years of age.

Other medicines and VFEND

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, even those without a prescription.

Some medicines can affect or be affected by the simultaneous use of VFEND.

Tell your doctor if you are taking the following medicines as VFEND should not be taken at the same time if it can be avoided:

  • Ritonavir (for the treatment of HIV ) in a dose of 100 mg twice daily.
  • Glasdegib (for cancer treatment) – if you need to be treated with both medicines, your doctor will do frequent checks on your heart rhythm.

Tell your doctor if you are taking any of the following medicines as co-treatment with VFEND should be avoided if possible, and dose adjustment of voriconazole may be necessary:

  • Rifabutin (for the treatment of tuberculosis ). If you are already being treated with rifabutin, your blood values ​​and side effects must be monitored .
  • Phenytoin (for the treatment of epilepsy ). If you are already being treated with phenytoin , the concentration of phenytoin in the blood must be monitored during treatment with VFEND and the dose may need to be adjusted.

Tell your doctor if you are taking any of the following medicines as a dose adjustment or check may be needed to make sure these medicines and/or VFEND are still having the desired effect:

  • warfarin and other anticoagulants (eg phenprocoumon, acenocoumarol) (used to inhibit the blood’s ability to clot)
  • ciclosporin (used in transplant patients)
  • tacrolimus (used in transplant patients)
  • sulfonylureas (eg tolbutamide, glipizide and glyburide) (used for diabetes )
  • statins (eg atorvastatin, simvastatin ) (cholesterol-lowering drugs)
  • benzodiazepines (eg midazolam, triazolam) (used for severe sleep disorders and stress)
  • omeprazole (used in the treatment of stomach ulcers )
  • Birth control pills (if you take VFEND while using birth control pills , you may experience side effects such as nausea and menstrual disturbances)
  • vinca alkaloids (eg vincristine and vinblastine) (used in the treatment of cancer)
  • tyrosine kinase inhibitors (eg axitinib, bosutinib, cabozantinib, ceritinib, cobimetinib, dabrafenib, dasatinib, nilotinib, sunitinib, ibrutinib, ribociclib) (used to treat cancer)
  • tretinoin (used in the treatment of leukemia )
  • indinavir and other HIV protease inhibitors (used in the treatment of HIV )
  • non-nucleoside reverse transcriptase inhibitors (eg, efavirenz, delavirdine, nevirapine) (used in the treatment of HIV ) (certain doses of efavirenz must NOT be used concurrently with VFEND)
  • methadone (used to treat heroin addiction)
  • alfentanil and fentanyl and other short-acting opiates such as sufentanil (painkillers used in surgery)
  • oxycodone and other long-acting opiates such as hydrocodone (used for moderate to severe pain)
  • non-steroidal anti-inflammatory drugs (eg ibuprofen , diclofenac ) (used to treat pain and inflammation )
  • fluconazole (used for fungal infections)
  • everolimus (used in the treatment of advanced kidney cancer and in transplant patients).
  • letermovir (used to prevent cytomegalovirus ( CMV ) disease after bone marrow transplantation)
  • ivacaftor (used in the treatment of cystic fibrosis ).

Pregnancy, breastfeeding and fertility

VFEND must not be taken during pregnancy, unless prescribed by a doctor. Effective contraception must be used by women of childbearing age. Contact your doctor immediately if you become pregnant while taking VFEND.

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine.

Driving ability and use of machinery

VFEND may cause blurred vision or unpleasant sensitivity to light. While you are experiencing something like this, do not drive, use tools or machines. Contact a doctor if you experience this.

VFEND contains lactose

If you have been told by your doctor that you have an intolerance to some sugars, you should contact your doctor before taking VFEND.

VFEND contains sodium

This medicine contains less than 1 mmol (23 mg) of sodium per 50 mg tablet, i.e. it is almost “sodium-free”.

This medicine contains less than 1 mmol (23 mg) of sodium per 200 mg tablet, i.e. it is almost “sodium-free”.

How to use VFEND

Always take this medicine as directed by your doctor. Ask your doctor or pharmacist if you are unsure.

Your doctor will decide your dose depending on your weight and the type of infection you have.

The recommended dose for adults (including elderly patients) is as follows:

Tablets
 Patients 40 kg or morePatients under 40 kg
Dose one for the first 24 hours(Load dosage)400 mg every 12 hoursin the first 24 hours200 mg every 12 hoursin the first 24 hours
Dose after the first 24 hours(Maintenance dose)200 mg twice daily100 mg twice daily

Depending on how the treatment works, the doctor may prescribe an increase in the dose from one to 300 mg twice daily.

The doctor may prescribe a reduction in dose if you have mild to moderate liver dysfunction.

Use for children and adolescents

The recommended dose for children and adolescents is:

Tablets
 Children from 2 years and up to 12 years and young people aged 12-14 who weigh less than 50 kgYouth 12 -14 years of age weighing more than 50 kg; and young people older than 14 years
Dose one for the first 24 hours(Load dosage)Treatment will be started as an infusion400 mg every 12 hoursin the first 24 hours
Dose after the first 24 hours(Maintenance dose)9 mg/kg twice daily(maximum dose is 350 mg twice daily)200 mg twice daily

Depending on how the treatment works, the doctor may increase or decrease the daily dose .

  • Tablets may only be given to children who can swallow tablets.

Take your tablet at least one hour before, or one hour after, a meal. Swallow the tablet whole with water.

If you or your child are taking VFEND to prevent fungal infections, the doctor may stop giving VFEND if you or your child develop side effects caused by the treatment.

If you use too much VFEND 

If you take more VFEND than prescribed (or if someone else takes your tablets), you must consult a doctor or go immediately to the emergency department of the nearest hospital. Bring your pack of VFEND tablets. You may notice an abnormal sensitivity to light if you take too much VFEND.

If you forget to take VFEND

It is important that you take your VFEND tablets regularly at the same time each day. If you forget to take a dose , take the next dose as planned. Do not take a double dose to make up for a missed dose .

If you stop taking VFEND

It has been shown that the effect of your medicine can be significantly increased if all doses are taken at the right time. Therefore, unless your doctor tells you to stop treatment, it is important to continue taking VFEND as described above.

Keep taking VFEND until your doctor tells you to stop. Do not stop treatment prematurely as your infection may not clear up. Patients with a weakened immune system or patients with severe infections may need long-term treatment to prevent the infection from recurring.

When treatment with VFEND is stopped by your doctor, you should not notice any effect.

If you have any further questions about this medicine, ask your doctor, pharmacist or nurse.

Possible side effects

Like all medicines, this medicine can cause side effects , although not everybody gets them.

If any side effects occur, most are likely to be minor or temporary. However, some can be serious and require medical attention.

Serious side effects – Stop taking VFEND and see a doctor immediately

  • rash
  • jaundice; changes in blood tests that test liver function
  • inflammation of the pancreas

Other side effects ar

Very common (may affect more than 1 in 10 people):

  • visual impairment (visual changes, including blurred vision, altered color vision, abnormal hypersensitivity to light, color blindness, eye disorders, experience of halo phenomenon, night blindness , oscillating visual experience, flashes in the visual field , visual aura , decreased visual acuity , enhanced visual experience of light, loss of parts of the normal field of vision et, spots in front of the eyes (fly vision))
  • fever
  • rash
  • nausea, vomiting, diarrhoea
  • headache
  • swollen arms and legs
  • stomach pains
  • breathing difficulties
  • elevated liver enzyme levels.

Common (may affect up to 1 in 10 people):

  • sinusitis, inflammation of the gums, chills, weakness
  • reduced number, even severe, of certain types of red (sometimes immune-related) and/or white blood cells (sometimes with fever), reduced number of thrombocytes ( platelets ) – cells that help with blood clotting
  • low blood sugar, low level of potassium in the blood, low level of sodium in the blood
  • anxiety, depression, confusion, restlessness, difficulty sleeping, hallucinations
  • seizures, tremors or uncontrolled muscle movements, tingling or abnormal skin sensations, increased muscle tension, sleepiness, dizziness
  • bleeding in the eye
  • heart rhythm disorders, including very fast heartbeats, very slow heartbeats, fainting
  • low blood pressure , inflammation of a blood vessel (which can cause blood clots)
  • acute breathing problems, chest pain, swelling of the face (mouth, lips and around the eyes), water in the lungs
  • constipation, indigestion, inflammation of the lips
  • jaundice, inflammation of the liver and liver damage
  • skin rash that can lead to severe blistering and scaling of the skin characterized by a flat, red area of ​​skin covered in small confluent bumps, redness of the skin
  • itching
  • hair loss
  • back pain
  • kidney failure , blood in the urine, altered kidney function values.

Uncommon (may affect up to 1 in 100 people):

  • flu-like symptoms , irritation and inflammation of the gastrointestinal tract, inflammation of the gastrointestinal tract causing antibiotic-associated diarrhea, inflammation of the lymphatic vessels
  • inflammation of the thin membrane that covers the inside of the abdominal wall and the abdominal organs
  • enlarged lymph nodes (sometimes painful), bone marrow failure , increased levels of eosinophils
  • impaired adrenal function, underactive thyroid gland
  • abnormal brain function, Parkinson-like symptoms, nerve damage that causes numbness, pain, tingling or burning in the hands or feet
  • impaired balance and coordination
  • brain swelling
  • double vision, serious eye conditions including: pain and inflammation of the eye and eyelid, abnormal eye movements, damage to the optic nerve leading to visual impairment, swelling of the optic nerve papilla
  • impaired sense of touch
  • altered sense of taste
  • hearing difficulties, ringing in the ears, vertigo
  • inflammation of certain internal organs – the pancreas and duodenum , swelling of and inflammation of the tongue
  • liver enlargement, liver failure, gallstones, gallstones
  • joint inflammation, inflammation of veins under the skin (which may be associated with blood clot formation)
  • nephritis, protein in the urine, kidney damage
  • very fast pulse or skipped heartbeats, sometimes with irregular electrical impulses
  • abnormal EKG
  • increased level of cholesterol in the blood, increased level of urea in the blood
  • allergic skin reactions (sometimes serious), including life-threatening skin diseases that cause painful blisters and sores on the skin and mucous membranes, especially in the mouth, inflammation of the skin, hives , sunburn or severe skin reactions after exposure to light or sun, skin redness and skin irritation, red or purple discoloration of the skin which may be due to a reduced number of platelets , eczema
  • infusion site reaction.
  • allergic reactions or excessive immune response

Rare (may affect up to 1 in 1,000 people):

  • overactive thyroid
  • impaired brain function which is a serious complication of liver disease
  • loss of most of the fibers in optic nerve one, clouding of the cornea, involuntary eye movements
  • bullous photosensitivity
  • a disorder in which the body’s immune system attacks parts of the peripheral nervous system
  • disturbances of the heart rhythm or conduction in the heart (sometimes life-threatening)
  • life-threatening allergic reaction
  • changes in the blood’s ability to clot
  • allergic skin reactions (sometimes severe) including rapid swelling ( oedema ) of the “leather skin” ( dermis ), subcutaneous tissue , mucous membranes and sub-mucosal tissue , itchy or sore patches of thick, red skin with silvery scales, irritation of the skin and mucous membranes, life-threatening skin disease which causes large parts of the skin’s outermost layer ( epidermis ) to detach from the underlying skin layer
  • small patches of dry and scaly skin, sometimes thickened with corns.

Adverse effects with no known frequency:

  • freckles and pigment spots.

Other important side effects are whose frequency is not known but which should be reported to the doctor immediately

  • skin cancer
  • inflammation of the tissue surrounding the bone
  • red, scaly patches or ring-shaped skin changes which may be symptoms of an autoimmune disease called cutaneous lupus erythematosus.

Because VFEND can affect the liver and kidneys, your doctor should check your liver and kidney function by doing blood tests. Tell your doctor if you have a stomach ache or if your stool has a different consistency.

Skin cancer has been reported in patients treated with VFEND during long-term treatment.

Sun damage or severe skin reaction after exposure to light or sun was more common in children. If you or your child develop skin changes, the doctor may refer you or your child to a dermatologist who, after consultation, may decide that it is important for you or your child to have regular check-ups.

Elevated liver enzyme levels were also seen more often in children.

If any of these side effects do not go away or are bothersome, tell your doctor.

How to store VFEND

Keep this medicine out of the sight and reach of children.

Use before the expiry date stated on the label. The expiration date is the last day of the specified month.

No special storage instructions.

Medicines must not be thrown into the drain or among household waste. Ask the pharmacist how to dispose of medicines that are no longer used. These measures will help to protect the environment.

Contents of the packaging and other information

Contents declaration

  • The active substance is voriconazole. Each tablet contains 50 mg voriconazole (for VFEND 50 mg film-coated tablets) or 200 mg voriconazole (for VFEND 200 mg film-coated tablets).
  • Other ingredients are lactose monohydrate , pregelatinized starch , croscarmellose sodium, povidone and magnesium stearate which make up the tablet core and hypromellose, titanium dioxide (E171), lactose monohydrate and glycerol triacetate which make up the film coating (see section 2, VFEND 50 mg film-coated tablets or VFEND 200 mg film-coated tablets contain lactose and sodium ).

Appearance and package sizes of the medicine

VFEND 50 mg film-coated tablets are supplied as white to off-white round film-coated tablets marked Pfizer on one side and VOR50 on the other.

VFEND 200 mg film-coated tablets are supplied as white to off-white capsule-shaped tablets marked Pfizer on one side and VOR200 on the other.

VFEND 50 mg film-coated tablets and 200 mg film-coated tablets are available in pack sizes of 2, 10, 14, 20, 28, 30, 50, 56 and 100 tablets.

Not all pack sizes may be marketed.

Marketing authorization holder and manufacturer

Pfizer Europe MA EEIG, Boulevard de la Plaine 17, 1050 Bruxelles, Belgium

Manufacturer

R-Pharm Germany GmbH

Heinrich-Mack-Str. 35, 89257 Illertissen,

Germany

Pfizer Italia Srl

Località Marino del Tronto

63100 Ascoli Piceno (AP)

Italy

Contact the representative of the Marketing Authorization Holder if you would like to know more about this medicine:

België /Belgique/Belgien/ Luxembourg/LuxemburgPfizer NV/SA Tél/Tel: +32 (0)2 554 62 11LithuaniaPfizer Luxembourg SARLfililas LietuvojeTel. +3705 2514000
BulgariaPfizer Luxembourg САРЛ, Клон Булгарияtel.: +3592 970 43 33Luxembourg/LuxembourgPfizer SATel: +32 (0)2 554 62 11
Czech RepublicPfizer, coil. sroPhone: +420-283-004-111MagyarországPfizer Kft.Tel. + 36 1 488 37 00
DenmarkPfizer ApSPhone: +45 44 20 11 00MaltaVJ Salomone Pharma Ltd.Phone: +356 21 22 01 74
DeutschlandPFIZER PHARMA GmbH Tel: +49 (0)30 550055-51000The NetherlandsPfizer bvPhone: +31 (0)800 63 34 636
EstoniaPfizer Luxembourg SARL Eesti branchPhone: +372 6 66 7500NorwayPfizer ASPhone: +47 67 52 61 00
GreecePfizer ΕΛΛΑΣ AETel.: +30 210 6785 800AustriaPfizer Corporation Austria Ges.mbHPhone: +43 (0)1 521 15-0
SpainPfizer, SLPhone: +34 91 490 99 00PolishPfizer Polska Sp. z o. o.Tel.: +48 22 335 61 00
FrancePfizerTel: +33 (0)1 58 07 34 40PortugalLaboratórios Pfizer, Lda.Phone: + 351 214 235 500
HrvatskaPfizer Croatia dooPhone: +385 1 3908 777RomaniaPfizer România SRLPhone: +40 (0)21 207 28 00
IrelandPfizer Healthcare IrelandTel: 1800 633 363 (toll free)+44 (0)1304 616161SlovenijaPfizer Luxembourg SARLPfizer, branch of marketing, LjubljanaPhone: + 386(0)152 11 400
IcelandIcepharma hf.,Telephone: + 354 540 8000Slovenian RepublicPfizer Luxembourg SARL, organizačná zložkaPhone: +421–2–3355 5500
ItalyPfizer SrlPhone: +39 06 33 18 21Finland/FinlandPfizer OyPhone/Tel: +358(0)9 43 00 40
CyprusPfizer ΕΛΛΑΣ Α.Ε. (Cyprus Branch)Phone: +357 22 817690SwedenPfizer ABPhone: +46 (0)8 5505 2000
LatviaPfizer Luxembourg SARLBranch in LatviaPhone: +371 670 35 775United Kingdom (Northern Ireland)Pfizer LimitedPhone: +44 (0)1304 616161

Leave a Reply